Top Gainers & Losers on September 26: Wockhardt, Vodafone Idea, PB Fintech, Eternal, Sail, Coforge among top losers today

The sale in the Indian stock market increased on Friday, September 26, while Freshwinds still weighs in Dalal Street, with investors who have cautious, risky bets and have driven shares to a low of the month. Although markets opened the session with a light cut, the sale deepened during the second half of the trade. The Nifty 50 expanded its loss of loss to a sixth consecutive session, which still dropped 0.95% to establish at 24,654 points, while the S&P BSE Sensex closed at 80,426, 0.90% lower than the previous closure. For the week, the Nifty 50 finished with 2.67%, which has been the biggest weekly fall in the last six months and wiped out 90% of profits after the GST reforms were announced on September 3. The Sensex also dropped by 2.70% for the week, the biggest decline since April 2025. The broader markets also suffered a steep loss, with the 1 -and -small -and -small -small -small loss, the 1.82% dropped and the age of 1 -year -old dropped. 2%, respectively. Both indexes ended the week lower by up to 5%. Friday’s accident was again led by technological stocks, with Pharma also joining the decline. Sector -wise closed all major sectoral indices in red, with a Nifty coming up as the top sector laggard, which fell 2.45% on Friday and ended the week by 8%, which was its biggest weekly decline since April 2025. This was followed by Nifty Pharma, who lost 2.13% in the session. Other indices, including Nifty Metal, Nifty Psu Bank, Nifty Media and Nifty 50, also closed lower by more than 1%. Pharma, Tech shares lead Friday’s accident more than 100 Nifig 500 businesses with losses of more than 3%, led by pharmaceutical shares such as Wockhardt, Laurus Labs, Neuland Laboratories, Biocon and Zydus Lifeciences, which dropped to 9.2%. The decline was caused after US President Donald Trump announced a 100% tariff on the import of brand and patented medicine, with effect from October 1, unless companies erected manufacturing plants in the United States. Analysts believe the 100% US tariff on brand and patented pharmaceutical products could significantly affect Indian pharmaceutical exporters, as the US is the largest market for Indian pharmaceutical pharmaceutical, which is about 35% of the $ 10 billion export in FY25, according to the Pharmaceutical Executive Council. Meanwhile, it has come under another round of sales pressure, with Oracle Financial Services, Coforge, persistent systems and MPhasis falling between 3% and 4.5%. Vodafone IDEA shares also flourished 7.6% to £ 8 each after reports that the Supreme Court has postponed its plea for additional fees. Metal supplies such as Hindustan buyer, Hindustan sink, sail and NMDC steel were also one of the top delays, which dropped to 5%. Car shares, which defended the recent sale, also came under pressure, with Mahindra & Mahindra and Hyundai car India, each more than 3%. Technical shares in the new age, including PB Fintech, Brainbees solutions, Honasa consumer and eternal, closed lower in the region of 3% to 4.5%. (More to come)